Zeini Maya, Laurenti Marcello C, Egan Aoife M, Muthusamy Kalpana, Ramar Anisha, Vella Emma, Bailey Kent R, Cobelli Claudio, Dalla Man Chiara, Vella Adrian
Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, MN.
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.
Diabetes. 2024 Sep 1;73(9):1440-1446. doi: 10.2337/db24-0192.
The T allele at rs7903146 in TCF7L2 increases the rate of conversion from prediabetes to type 2 diabetes. This has been associated with impaired β-cell function and with defective suppression of α-cell secretion by glucose. However, the temporal relationship of these abnormalities is uncertain. To study the longitudinal changes in islet function, we recruited 128 subjects, with 67 homozygous for the diabetes-associated allele (TT) at rs7903146 and 61 homozygous for the protective allele. Subjects were studied on two occasions, 3 years apart, using an oral 75-g glucose challenge. The oral minimal model was used to quantitate β-cell function; the glucagon secretion rate was estimated from deconvolution of glucagon concentrations. Glucose tolerance worsened in subjects with the TT genotype. This was accompanied by impaired postchallenge glucagon suppression but appropriate β-cell responsivity to rising glucose concentrations. These data suggest that α-cell abnormalities associated with the TT genotype (rs7903146) occur early and may precede β-cell dysfunction in people as they develop glucose intolerance and type 2 diabetes.
TCF7L2基因中rs7903146位点的T等位基因会增加从糖尿病前期转变为2型糖尿病的几率。这与β细胞功能受损以及葡萄糖对α细胞分泌的抑制缺陷有关。然而,这些异常情况的时间关系尚不确定。为了研究胰岛功能的纵向变化,我们招募了128名受试者,其中67名在rs7903146位点为与糖尿病相关的等位基因纯合子(TT),61名是保护性等位基因纯合子。受试者在相隔3年的两个时间点接受了口服75克葡萄糖耐量试验。采用口服最小模型来定量β细胞功能;通过对胰高血糖素浓度进行反卷积分析来估计胰高血糖素分泌率。TT基因型受试者的葡萄糖耐量恶化。这伴随着口服葡萄糖后胰高血糖素抑制功能受损,但β细胞对血糖浓度升高有适当的反应性。这些数据表明,与TT基因型(rs7903146)相关的α细胞异常出现较早,在人们发生葡萄糖不耐受和2型糖尿病时,可能先于β细胞功能障碍出现。